Annual Operating Expenses
$16.14 M
+$7.92 M+96.39%
December 31, 2023
Summary
- As of February 12, 2025, IMMX annual total operating expenses is $16.14 million, with the most recent change of +$7.92 million (+96.39%) on December 31, 2023.
- During the last 3 years, IMMX annual operating expenses has risen by +$15.69 million (+3456.09%).
- IMMX annual operating expenses is now at all-time high.
Performance
IMMX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$7.39 M
+$2.69 M+57.25%
September 30, 2024
Summary
- As of February 12, 2025, IMMX quarterly total operating expenses is $7.39 million, with the most recent change of +$2.69 million (+57.25%) on September 30, 2024.
- Over the past year, IMMX quarterly operating expenses has increased by +$2.87 million (+63.47%).
- IMMX quarterly operating expenses is now at all-time high.
Performance
IMMX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IMMX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.4% | +63.5% |
| 3 y3 years | +3456.1% | +63.5% |
| 5 y5 years | +1815.9% | +63.5% |
IMMX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1093.9% | at high | +1136.0% |
| 5 y | 5-year | at high | +3456.1% | at high | +8008.4% |
| alltime | all time | at high | +3456.1% | at high | +8008.4% |
Immix Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.39 M(+57.3%) |
| Jun 2024 | - | $4.70 M(-15.9%) |
| Mar 2024 | - | $5.59 M(+4.0%) |
| Dec 2023 | $16.14 M(+96.4%) | $5.38 M(+18.8%) |
| Sep 2023 | - | $4.52 M(+21.6%) |
| Jun 2023 | - | $3.72 M(+47.6%) |
| Mar 2023 | - | $2.52 M(-33.6%) |
| Dec 2022 | $8.22 M | $3.79 M(+147.5%) |
| Sep 2022 | - | $1.53 M(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.56 M(+17.4%) |
| Mar 2022 | - | $1.33 M(+122.3%) |
| Dec 2021 | $1.35 M(+197.9%) | $598.30 K(+71.9%) |
| Sep 2021 | - | $348.00 K(+43.1%) |
| Jun 2021 | - | $243.20 K(+49.7%) |
| Mar 2021 | - | $162.50 K(+5.8%) |
| Dec 2020 | $453.90 K(-46.1%) | $153.60 K(+68.4%) |
| Sep 2020 | - | $91.20 K |
| Dec 2019 | $842.50 K | - |
FAQ
- What is Immix Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for Immix Biopharma?
- What is Immix Biopharma annual operating expenses year-on-year change?
- What is Immix Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Immix Biopharma?
- What is Immix Biopharma quarterly operating expenses year-on-year change?
What is Immix Biopharma annual total operating expenses?
The current annual operating expenses of IMMX is $16.14 M
What is the all time high annual operating expenses for Immix Biopharma?
Immix Biopharma all-time high annual total operating expenses is $16.14 M
What is Immix Biopharma annual operating expenses year-on-year change?
Over the past year, IMMX annual total operating expenses has changed by +$7.92 M (+96.39%)
What is Immix Biopharma quarterly total operating expenses?
The current quarterly operating expenses of IMMX is $7.39 M
What is the all time high quarterly operating expenses for Immix Biopharma?
Immix Biopharma all-time high quarterly total operating expenses is $7.39 M
What is Immix Biopharma quarterly operating expenses year-on-year change?
Over the past year, IMMX quarterly total operating expenses has changed by +$2.87 M (+63.47%)